PBM practices drive up costs for Rx drugs

Wall Street Journal

24 February 2019 - As the only pharmacist currently serving in Congress, I was encouraged to read Dr. Scott Atlas’s “How to Reduce Prescription-Drug Prices: First, Do No Harm”.

I could not agree more that middlemen have way too much control in our current drug supply chain, and I’ve been very encouraged by the Trump administration’s efforts to rein in the market tactics used by pharmacy-benefit managers.

Read Wall Street Journal article (subscription required)


Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Pharmacy